BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18534716)

  • 1. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.
    Pollack CV; Varon J; Garrison NA; Ebrahimi R; Dunbar L; Peacock WF
    Ann Emerg Med; 2009 Mar; 53(3):329-38. PubMed ID: 18534716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clevidipine for the treatment of severe hypertension in adults.
    Nguyen HM; Ma K; Pham DQ
    Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
    Aronson S
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):465-72. PubMed ID: 19419254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO).
    Peacock WF; Chandra A; Char D; Collins S; Der Sahakian G; Ding L; Dunbar L; Fermann G; Fonarow GC; Garrison N; Hu MY; Jourdain P; Laribi S; Levy P; Möckel M; Mueller C; Ray P; Singer A; Ventura H; Weiss M; Mebazaa A
    Am Heart J; 2014 Apr; 167(4):529-36. PubMed ID: 24655702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
    Frank Peacock W; Varon J; Ebrahimi R; Dunbar L; Pollack CV
    Blood Press Suppl; 2011 Apr; 1(Suppl 1):20-5. PubMed ID: 21091269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.
    Barrett TW; Schriger DL
    Ann Emerg Med; 2009 Aug; 54(2):301-7. PubMed ID: 19616729
    [No Abstract]   [Full Text] [Related]  

  • 9. Clevidipine for controlled hypotension during spinal surgery in adolescents.
    Tobias JD; Hoernschemeyer DG
    J Neurosurg Anesthesiol; 2011 Oct; 23(4):347-51. PubMed ID: 21623231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.
    Erickson AL; DeGrado JR; Fanikos JR
    Pharmacotherapy; 2010 May; 30(5):515-28. PubMed ID: 20412001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
    Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC
    Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clevidipine butyrate: a promising new drug for the management of acute hypertension.
    Bergese SD; Puente EG
    Expert Opin Pharmacother; 2010 Feb; 11(2):281-95. PubMed ID: 20088748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis.
    Peacock F; Varon J; Ebrahimi R; Dunbar L; Pollack CV
    Congest Heart Fail; 2010; 16(2):55-9. PubMed ID: 20412469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clevidipine for controlled hypotension during spinal surgery in adolescents.
    Tobias JD
    Middle East J Anaesthesiol; 2011 Jun; 21(2):269-74. PubMed ID: 22435279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises.
    Hirschl MM; Binder M; Bur A; Herkner H; Brunner M; Müllner M; Sterz F; Laggner AN
    Arch Intern Med; 1995 Nov; 155(20):2217-23. PubMed ID: 7487244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nicardipine for treatment of severe hypertension in children.
    Flynn JT; Mottes TA; Brophy PD; Kershaw DB; Smoyer WE; Bunchman TE
    J Pediatr; 2001 Jul; 139(1):38-43. PubMed ID: 11445792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.